| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 31,253 | 31,637 | 26,124 | 34,890 | | Cost of Revenue | 23,556 | 47,235 |
-
| 26,550 | | | Gross Profit | 7,697 | (15,598) | 26,124 | 8,340 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,906 | (21,782) | 26,007 | 2,368 | | Non Recurring |
-
|
-
|
-
| 116,443 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,791 | 6,184 | 117 | (110,471) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (43) | 28 | 4 | (49) | | Earnings Before Interest And Taxes | 5,748 | 6,212 | 121 | (110,520) | | Interest Expense | 1,386 | 1,430 | 773 | 1,413 | | Income Before Tax | 4,362 | 4,782 | (652) | (111,933) | | Income Tax Expense | 1,892 | 2,108 | (290) | (37,974) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,470 | 2,674 | (362) | (73,959) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,470 | 2,674 | (362) | (73,959) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,470 | $2,674 | ($362) | ($73,959) |
|
0.01% Nasdaq 
0.45%
Income Statement
